Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps  Latest publication
SARS-CoV-2 RBD-Fc
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/27/2020
RBD-NVP
Potential treatment - pre-clinical evidence Experimental Vaccine Dec/20/2020
LV::SFL
Potential treatment - pre-clinical evidence Experimental Vaccine Dec/16/2020
Inactivated SARS-CoV-2 vaccine
Potential treatment - clinical evidence Experimental Vaccine Nov/09/2020
mRNA-1273
Emergency use authorization Experimental Vaccine Jun/22/2022
Gam-COVID-Vac
Emergency use authorization Experimental Vaccine Dec/23/2021
RBD immunogen
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/11/2021
rVSV-∆G-spike
Potential treatment - pre-clinical evidence Experimental Vaccine Dec/16/2020
ELI-005
Potential treatment - pre-clinical evidence Experimental Vaccine Feb/05/2021
ChAd-SARS-CoV-2-S
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/17/2021
rAd5-S
Potential treatment - clinical evidence Experimental Vaccine Sep/04/2020
rAd26-S
Potential treatment - clinical evidence Experimental Vaccine Sep/04/2020
Ad5-S-nb2
Potential treatment - pre-clinical evidence Experimental Vaccine Aug/21/2020
RQ3013-VLP
Potential treatment - pre-clinical evidence Experimental Vaccine Aug/17/2020
rMeV-preS
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/09/2021
rMVAs
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/09/2021
WIV04 strain vaccine
Potential treatment - clinical evidence Experimental Vaccine Aug/13/2020
CoronaVac
Potential treatment - clinical evidence Experimental Vaccine Apr/06/2021
RBD mRNA
Potential treatment - pre-clinical evidence Experimental Vaccine Aug/05/2020
S1 mRNA
Potential treatment - pre-clinical evidence Experimental Vaccine Aug/05/2020